IREN
IREN Limited
There isn't enough reported data to score IREN yet.
MNSB
MainStreet Bancshares, Inc.
MNSB's fundamentals are strong, but it looks expensive: trading at 11x earnings, above its usual 9.1x. Analysts expect earnings growth.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
MNSB Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
MNSB's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like MNSB.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
MNSB PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.4x | $12.45 | -42% |
| Fair | 9.1x | $17.67 | -18% |
| Forward | 10x | $21.45 | — |
| Current | 11x | $21.45 | — |
| Expensive | 12x | $22.58 | +5.3% |
Historical ranges are pointers, not guarantees.
MNSB's PE is in its expensive range at 11x. If earnings grow as analysts expect, today's price would be 10x next year's earnings.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
MNSB Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for MNSB, with profitability holding steady.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
MNSB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.07 | +6.2% |
| Q3 2026 | $1.95 | +$2.84 |
| Q2 2026 | $2.04 | +$3.49 |
| Q1 2026 | $1.99 | +$3.70 |
| Q4 2025 | $1.76 | +$3.36 |
| Q3 2025 | -$0.89 | -174% |
| Q2 2025 | -$1.45 | -172% |
| Q1 2025 | -$1.71 | -166% |
| Q4 2024 | -$1.60 | -149% |
MNSB has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
MNSB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $19.4M | +6.7% |
| Q2 2026 | $19.1M | -3.7% |
| Q1 2026 | $17.9M | +2.6% |
| Q4 2025 | $18M | +7.1% |
| Q3 2025 | $18.2M | +12% |
| Q2 2025 | $19.9M | +23% |
| Q1 2025 | $17.4M | +7.3% |
| Q4 2024 | $16.8M | -5.7% |
MNSB's revenue has held roughly level: $19M last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 24% | -5.8 points |
| Q2 2026 | 32% | +3 points |
| Q1 2026 | 30% | +12 points |
| Q4 2025 | 27% | +152 points |
| Q3 2025 | 30% | +29 points |
| Q2 2025 | 28% | +11 points |
| Q1 2025 | 18% | -7.5 points |
| Q4 2024 | -125% | -160 points |
MNSB has the edge over IREN on profitability, with a higher operating margin.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
MNSB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $5.8M | +6.4% |
| Q2 2026 | $4.8M | +$7.5M |
| Q1 2026 | $6.5M | +366% |
| Q4 2025 | $6.4M | +19% |
| Q3 2025 | $5.5M | +27% |
| Q2 2025 | -$2.6M | -345% |
| Q1 2025 | $1.4M | -54% |
| Q4 2024 | $5.4M | +1.8% |
MNSB has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
MNSB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -57.9K shares |
| 1 year | -7.6% | -585K shares |
| 3 years | -5.4% | -405K shares |
| 5 years | -6% | -452K shares |
| Available history | -14% | -1.1M shares |
MNSB has the edge over IREN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $5M |
| Q1 2026 | $6.1M |
| Q4 2025 | $3.9M |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $446,000 |
| Q4 2024 | $13,000 |
MNSB spent $15M buying back its own shares over the past year, more than ten times what it spent the year before.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
MNSB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.5x | Healthy |
| Q1 2026 | 1.5x | Healthy |
| Q4 2025 | 1.9x | Healthy |
| Q3 2024 | 1.9x | Healthy |
| Q2 2024 | 1.3x | Healthy |
| Q1 2024 | 0.8x | Very low |
| Q4 2023 | 0.5x | Very low |
MNSB's net debt is about 1.7 years of its operating earnings (EBITDA), down from 1.9 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MNSB.
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
MNSB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.4 | Neutral |
| Stochastic | 16.6 | Oversold |
MNSB's weekly RSI is 38 (neutral) and its Stochastic is 17 (oversold).
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
MNSB PE vs Financial Services Sector
| Metric | MNSB | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 13x | 16% below |
| PE % | 75 | 63 | 12 pts above |
MNSB is trading at 11x earnings, a 16% discount to the Financial Services sector's median of 13x.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
MNSB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $23.5 | 8.5% below |
| 20 week MA | $24.1 | 11% below |
| 50 week MA | $23.0 | 6.8% below |
| 100 week MA | $20.9 | 2.7% above |
| 200 week MA | $20.8 | 3.2% above |
MNSB has the edge over IREN on trend strength, trading above more of its moving averages.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.
MNSB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $23.0 | $16.8 | -27% |
| 2021 | $16.8 | $23.8 | +42% |
| 2022 | $23.8 | $27.4 | +15% |
| 2023 | $27.4 | $24.8 | -9.3% |
| 2024 | $24.8 | $18.0 | -27% |
| 2025 | $18.0 | $21.0 | +17% |
| 2026 YTD | $21.0 | $21.5 | +2.1% |
MNSB has the edge over IREN on returns for 2026, with the stronger performance.